For instance, TWIK‐related acid‐sensitive potassium channel 1 (TASK‐1 or KCNK3) has been identified as a potential therapeutic target in lung adenocarcinoma, as it inhibits proliferation and glucose metabolism through the activation of the AMPK–TXNIP pathway.132. Here, KCNK3 is linked to lung adenocarcinoma.